InjuryBoard Los Angeles Archives

• Slow Response for Mercury Spill on Los Angeles Subway

  Shannon Weidemann | February 26, 2007 11:39 AM | 0 Comments
  Category: Toxic Substances

  Los Angeles's subway stations are unattended and monitored only by closed circuit television cameras. In December a man spilled mercury on the platform at one of the stations and contacted the Metro Transit Authority on what he had done. It took 8 hours before anything was done to clean up the spill. In the meantime several passengers of the subway came in contact with the hazardous...

• FDA Demands New Warnings for ADHD Drugs

  Paul Kiesel | February 26, 2007 3:00 AM | 0 Comments
  Category: Defective & Dangerous Products

  FDA requires new ADHD warning labels. Added warnings advised on ADHD drugs.An FDA advisory panel voted on Thursday to recommend the most serious type of warning labels for drugs treating attention deficit hyperactivity disorder. The new warning will include cautionary language of those medications causing psychiatric and heart problems, including death.Approximately 3.3 million children and 1.5...

• New Study Links Heart Surgery Drug to Increased Risk of Death

  Paul Kiesel | February 12, 2007 3:00 AM | 0 Comments
  Category: Defective & Dangerous Products

  Trasylol linked to increased risk of death. New study reports heart surgery drug increases risk of death. Aprotinin, a drug commonly used to prevent bleeding during heart surgery increases the risk of dying in the five years after surgery by almost 50 percent. That is the conclusion of a recent study published on Wednesday in JAMA, the Journal of the American Medical Association. The study...

• FDA Promises More Focus on Drug Safety

  Paul Kiesel | February 05, 2007 3:00 AM | 0 Comments
  Category: Defective & Dangerous Products

  FDA pledges to improve its safety program. New promises from the FDA. Last week the Food and Drug Administration promised to make significant changes to the U.S. drug safety program. Its pledge comes as a result of last falls scathing report issued by a blue ribbon panel that found the FDA's drug safety program is in serious need of change. Specifically, the panel found that FDA officials were...